Envista Holdings NVST
NYSE NVST
$23.63 +0.44 (+1.90%)
As of: Oct 22, 2026 · 10:29 AM EDT

Envista Holdings (NVST) Long-Term Debt Repayments (2020 - 2024)

Updated

Envista Holdings (NVST) recorded Long-Term Debt Repayments of $116.3 million in FY2025, up 16.3% from $100 million in FY2024.

Analysis

Envista Holdings (NVST) Long-Term Debt Repayments (2020 - 2024) Analysis & Trends

Starting with FY2020, Envista Holdings' Long-Term Debt Repayments history includes 5 years.

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
  • Annual Long-Term Debt Repayments has ranged from $100 million in FY2024 to $401.2 million in FY2023 over the past five years.
  • Per Business Quant data, NVST's Long-Term Debt Repayments was $100 million in FY2024 (-75.1%), $401.2 million in FY2023 (+223.5%) and $124 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 252.57 Bn 231.60 Bn 4.88 Bn -
2 Abbott Laboratories 176.08 Bn 146.51 Bn 7.27 Bn 1.41 Bn
3 Danaher 163.92 Bn 147.72 Bn 3.61 Bn -
4 Intuitive Surgical 155.68 Bn 135.10 Bn 1.96 Bn -
5 Medtronic 121.40 Bn 86.65 Bn 6.34 Bn -
6 Stryker 117.11 Bn 103.23 Bn 4.50 Bn -
7 Boston Scientific 66.70 Bn 61.47 Bn 3.85 Bn -
8 Becton Dickinson 54.26 Bn 51.41 Bn 2.32 Bn 2.00 Bn
9 Edwards Lifesciences 51.46 Bn 35.46 Bn 1.35 Bn -
10 Envista Holdings 3.84 Bn -716.97 Mn 407.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2024 100.00 Mn
Dec 31, 2022 70.50 Mn
Oct 2, 2020 249.90 Mn
API Access

Envista Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NVST&period=max&api_key=YOUR_API_KEY